Celebrex NewsGet the Latest Celebrex News |
| Bookmark This Page |
[ Defective Defibrillators ]
[ Tardive Dyskinesia ]
[ Defective Heart Valves ]
[ Zyprexa ]
[ Bextra ]
[ Ancure - Malfunctioning Device ]
[ Manganism ]
[ Silicosis ]
[ AML Leukemia ]
[ Paxil Side Effects ]
|
Sharepoint Mortgage Currency Teeth Whitening SAP Nouvelles de SAP SAP Nachrichten Obituary Software As A Service Bluetooth Product Recall Personal Injury DUI Business Software Medical Billing Software Laser Hair Removal Plastic Surgery Adipex Phentermine Petroleum Engineering Offshore Engineering CA |
Filings: Pfizer settles lawsuit involving Celebrex |
How pain medication Vioxx ups heart disease risk 
Washington, May 3 (ANI): After almost 13 years of study and intense debate, researchers have shed light on exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it. Scientists Spot How Cox-2 Painkillers Raise Heart Risks
WEDNESDAY, May 2 (HealthDay News) -- New research has uncovered how some cox-2 painkillers increase the risk for both heart attacks and stroke. WSJ BLOG/Health: Studies Shine Light on How Vioxx Raises Heart Risks
WSJ BLOG/Health: Studies Shine Light on How Vioxx Raises Heart Risks Vioxx Killed Half a Million? The Facts Are Grim.
It’s looking more and more likely that the Merck painkiller Vioxx, the blockbuster drug suspected of having caused more than 55,000 deaths from stroke and heart attack before being withdrawn from the market in 2004, actually killed many more people than we previously thought. While conducting research on America’s media coverage of the Vioxx scandal, publisher of The American Conservative Ron ... Studies Shine Light on How Vioxx Raises Heart Risks
Researchers have published the last of some 20 studies in humans and mice examining the underpinnings for the risks of taking Vioxx and related drugs. CrystalGenomics Announces Positive Results from Phase 2b Osteoarthritis Study of CG100649
SEOUL, South Korea, April 18, 2012 /PRNewswire/ -- CrystalGenomics, Inc., a biopharmaceutical company headquartered in Korea, has just announced positive results from the Phase 2b osteoarthritis (OA) study ... NSAIDs and Cardiovascular Risk Explained
After nearly 13 years of study and intense debate, a pair of new articles have confirmed exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it. Treating osteoarthritis
Posted: Wednesday, May 16, 2012 12:15 am | Updated: 2:12 am, Wed May 16, 2012. Osteoarthritis sufferers have traditionally relied on "non-steroidal anti-inflammatory drugs" (NSAIDs) to reduce joint pain and swelling. NSAIDs and Cardiovascular Risk Explained, According to Studies from the Perelman School of Medicine
PHILADELPHIA — After nearly 13 years of study and intense debate, a pair of new papers from the Perelman School of Medicine, at the University of Pennsylvania have confirmed exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it. Q&A with Garret FitzGerald, Univ. of Pennsylvania expert on drugs and heart risks
Thirteen years ago, Garret FitzGerald, chair of the department of pharmacology at the University of Pennsylvania, warned that new painkillers called COX-2 inhibitors might increase the risk of heart attacks and strokes. He was right. Since then, COX-2 inhibitors, notably Vioxx, have been yanked from the market or failed to win approval. Surviving brands have had to add a stern label warning ... Celebrex News - Get the Latest Celebrex News |
Copyright 2012
Get the Latest Celebrex News
http://news.search.yahoo.com/news/rss?p=Celebrex+&ei=UTF-8&fl=0&x=wrt
http://news.search.yahoo.com/news/rss?p=Celebrex+heart&ei=UTF-8&fl=0&x=wrt